Quetiapine fumarate marketed by AstraZeneca as Seroquel or SeroquelXR and by Orion Pharma as Ketipinor, is an atypical antipsychotic used in the management of schizophrenia, bipolar I mania, bipolar II depression, bipolar I depression, and used off-label for a variety of other purposes, including insomnia and anxiety disorders.

Dec 3, 2019 Second divestment to Germany-based Cheplapharm this year AstraZeneca has sold the commercial rights to schizophrenia and bipolar disorder

AstraZeneca previously divested the rights to Seroquel and Seroquel XR in the UK, Japan and other major international markets. AstraZeneca also agreed to divest the rights to the medicines in Europe (excluding the UK) and Russia to Cheplapharm earlier in 2019, a transaction that is expected to complete in the fourth quarter of 2019, subject to customary closing conditions and regulatory 2010-08-09 · AstraZeneca Plc will pay about $198 million to settle 17,500 lawsuits, or about two-thirds of the total cases alleging its antipsychotic drug Seroquel causes diabetes in some users. AstraZeneca is also defending Seroquel product liability claims in California, Alabama and Missouri. In May 2009, the judge presiding over the Seroquel litigation in the Superior Court of Delaware granted AstraZeneca's motion for summary judgment in the first Seroquel product liability case Important notice for users You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. 2011-07-28 · AstraZeneca Plc has settled almost all lawsuits that claimed its antipsychotic drug Seroquel causes diabetes in some users for a total of $647 million. 2018-08-07 · AstraZeneca has paid more than $1.3 billion to settle claims related to Seroquel and the company still faces another whistleblower suit filed in federal court in Delaware on behalf of the U.S. and AstraZeneca Seroquel Statement.

Under 2012 gick patenten för Astrazenecas läkemedel mot depression, Seroquel och Seroquel IR, ut på flera marknader vilket stod för det Läkemedelsjätten Astra Zeneca säljer rättigheterna till det antidepressiva läkemedlet Seroquel och Seroquel XR till Luye Pharma. Rättigheterna gäller för AstraZeneca Årsredovisning med information från Form 20-F 2010 tillväxt för läkemedel som Crestor, Symbicort och Seroquel XR. Iintäkterna Ändamål: skitsofrenia, kaksisuuntaisen mielialahäiriön hoito. Paketstorlek: 100 fol. Marknadsförare: AstraZeneca Oy. 87,16 €.

The main indications for Seroquel are the treatment of schizophrenia and bipolar disorder. Seroquel XR is also approved in some markets for major depressive disorder and generalised anxiety disorder. AstraZeneca has previously disposed of the rights to Seroquel and Seroquel XR in the UK, Japan and other major international markets. About AstraZeneca

AstraZeneca partnered the rights to Seroquel and Seroquel XR in Japan and Venezuela under prior agreements. Mark Mallon, Executive Vice President, Global Product and Portfolio Strategy, AstraZeneca, said: “The agreement with Luye Pharma is in line with AstraZeneca’s strategy to focus on three main therapy areas while maximising the value from our legacy medicines like Seroquel . AstraZeneca.

Sale to Cheplapharm supports AstraZeneca's focus on main therapy areas. AstraZeneca has agreed to sell the commercial rights to Seroquel

Seroquel Depot (parallellimporterat), Depottablett 400 mg . Orifarm. Substans (0) Sjukdom (0) Om Läkemedel > Vad är ett läkemedel?

Clinicians must take into account the safety concerns associated with antipsychotic drugs, a class of drugs to which SEROQUEL XR belongs.
Privatpaket loopia

AstraZeneca har ingått ett avtal om förlikning i patenttvisten i USA rörande Seroquel XR ®, med Handa Pharmaceuticals, LLC ("Handa") avseende Handas föreslagna generiska version av Seroquel XR är det enda läkemedlet i sin klass som godkänts av FDA både för egentlig depression, som tilläggsbehandling, och för akuta depressiva episoder vid bipolär sjukdom, som monoterapi. Astra Zeneca plc, marknadsfört som AstraZeneca, är ett svensk-brittiskt multinationellt läkemedelsbolag vars produkter säljs i mer än hundra länder. Bolaget bildades den 6 april 1999 genom en sammanslagning av två läkemedelskoncerner, svenska Astra AB och brittiska Zeneca Group plc. Huvudkontoret ligger i Cambridge.

Substans (0) Sjukdom (0) AstraZeneca ansöker om EU-godkännande för Seroquel vid mani fre, feb 07, 2003 10:30 CET AstraZeneca today announced that the US Food and Drug Administration (FDA) approved SEROQUEL (quetiapine fumarate) Tablets for the treatment of schizophrenia in adolescents (13-17 years of age) as monotherapy, and for the acute treatment of manic episodes associated with bipolar I disorder in children and adolescents (10-17 years of age), both as monotherapy and as an adjunct to lithium or divalproex. Seroquel XR is also approved in some markets for major depressive disorder and generalised anxiety disorder. About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory.
Elinstallationer i karlshamn

Enligt statsåklagaren ska Astrazeneca ha marknadsfört Seroquel för att användas även till annat än godkända indikationer och vilselett om

AstraZeneca, one of the country's biggest drug firms, allegedly pulled in hundreds of millions of taxpayer dollars through Medicare and Medicaid kickbacks and scams. Seroquel is used to treat schizophrenia in patients older than 13, and bipolar disorder in patients older than 10. REUTERS/Stefan Wermuth LONDON (Reuters) - Drugmaker AstraZeneca has agreed to pay $110 million to settle two lawsuits brought by the state of Texas claiming that it fraudulently marketed the Quetiapine fumarate marketed by AstraZeneca as Seroquel or SeroquelXR and by Orion Pharma as Ketipinor, is an atypical antipsychotic used in the management of schizophrenia, bipolar I mania, bipolar II depression, bipolar I depression, and used off-label for a variety of other purposes, including insomnia and anxiety disorders. If you are in the US and would like additional information regarding AstraZeneca drugs, please contact the Information Center at AstraZeneca at 800-236-9933 800-236-9933.